date:Jul 07, 2012
Russia and Serbia.Discussions with both countries have commenced, he said, however the strategy will be to bring the herbal preparation Inlacin to market as a supplement not a herbal drug as in Indonesia.
There are several complexities when entering a product into Russia, Aydogen detailed. A company must have at least one clinical trial conducted on Russian soil and the product must be reduced to its raw material and register this in the country - only then can you take the product to market in